EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder

Aida Alvarez iD, Valentin Bote iD, Cristina Lamborena, Raquel Medina, Alexandre Serra-LLovich iD, Amaia Hervas iD, Maria J Arranz iD

Pharmacogenomics · 2023

DOI: 10.2217/pgs-2023-0134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Aida Alvarez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child & Adolescent Psychiatry, Hospital Universitari Mútua Terrassa, Spain. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Pharmacogenetics, Psychotropic Drugs, Mental Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 70% of individuals diagnosed with autism spectrum disorder (ASD) receive at least one psychotropic medication to treat comorbidities. However, the response to treatment with these drugs is far from satisfactory, with 30-50% of treated patients not responding adequately or developing severe and long-lasting side effects. There is strong evidence of the clinical utility of pharmacogenetics for the personalization of antipsychotic and antidepressant treatments in adult populations. However, the use of pharmacogenetic interventions for the personalization of treatment in ASD populations is minimal. The aim of this review is to summarize the findings of pharmacogenetic studies conducted in subjects with ASD and illustrate their utility in the personalization of treatment with psychoactive drugs in this population group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderPharmacogeneticsPsychotropic DrugsMental DisordersHumansComorbidityAntipsychotic AgentsAntidepressive AgentsPrecision Medicine

Stichwörter der Autor:innen

antidepressantsautism spectrum disorderpersonalized medicine antipsychoticpharmacogeneticsreview

Substanzen

Psychotropic DrugsAntipsychotic AgentsAntidepressive Agents

Autor:innen und Institutionen

  • Department of Child & Adolescent Psychiatry, Hospital Universitari Mútua Terrassa, Spain.
  • Research Laboratory Unit, Fundació Docència i Recerca Mútua Terrassa, Spain.

ORCID-Profile: Aida Alvarez, Valentin Bote, Alexandre Serra-LLovich, Amaia Hervas, Maria J Arranz

Zitieren

APA

Alvarez, A., Bote, V., Lamborena, C., Medina, R., Serra-LLovich, A., Hervas, A., & Arranz, M. J. (2023). Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0134

Vancouver

Alvarez A, Bote V, Lamborena C, Medina R, Serra-LLovich A, Hervas A, et al. Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0134

BibTeX
@article{Alvarez2023,
  author = {Alvarez, Aida and Bote, Valentin and Lamborena, Cristina and Medina, Raquel and Serra-LLovich, Alexandre and Hervas, Amaia and Arranz, Maria J},
  title = {Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder},
  journal = {Pharmacogenomics},
  year = {2023},
  doi = {10.2217/pgs-2023-0134}
}
Kostenlos starten →